Jacinth Fairley
Director/Board Member bij MIRRABOOKA INVESTMENTS LIMITED
Vermogen: 425 311 $ op 31-03-2024
Profiel
Jacinth K.
Fairley is an Independent Non-Executive Director at Mirrabooka Investments Ltd.
She was previously the Chief Executive Officer, MD & Executive Director at Starpharma Holdings Ltd.
from 2006 to 2024.
She was also the Director at Melbourne Business School from 2010 to 2020.
Additionally, she is a Member of the Pharmaceutical Industry Working Group.
Fairley holds an MBA from Melbourne Business School and an undergraduate degree from the University of Melbourne.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-10-2023 | 4 055 434 ( 0.98% ) | 330 721 $ | 31-03-2024 | |
| 19-02-2024 | 43 540 ( 0.02% ) | 94 590 $ | 31-03-2024 |
Actieve functies van Jacinth Fairley
| Bedrijven | Functie | Begin |
|---|---|---|
| MIRRABOOKA INVESTMENTS LIMITED | Director/Board Member | 15-02-2018 |
Eerdere bekende functies van Jacinth Fairley
| Bedrijven | Functie | Einde |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Chief Executive Officer | 08-01-2024 |
| Melbourne Business School | Director/Board Member | 01-12-2020 |
| Pharmaceutical Industry Working Group | Corporate Officer/Principal | - |
Opleiding van Jacinth Fairley
| Melbourne Business School | Masters Business Admin |
| University of Melbourne | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Mirrabooka Investments Ltd.
 Mirrabooka Investments Ltd. Investment Trusts/Mutual FundsMiscellaneous Mirrabooka Investments Ltd. is closed-end investment fund/Investment trust. It invests in small and medium sized companies located in Australia and New Zealand. The company was founded in December 1998 and is headquartered in Melbourne, Australia. | Miscellaneous |
| Pharmaceutical Industry Working Group |
